Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimifix M 1 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimifix M 1 mg/500 mg Tablet

Diabex Duo 1 mg/500 mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your physician.

Uses of Glimifix M 1 mg/500 mg Tablet

Managing type 2 diabetes

Major Benefits of Glimifix M 1 mg/500 mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Consume the Glimifix M 1 mg/500 mg tablet with food.

Common Side effects of Glimifix M 1 mg/500 mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimifix M 1 mg/500 mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimifix M 1 mg/500 mg Tablet with a meal.

How Glimifix M 1 mg/500 mg Tablet works:

Glimifix M, a 1 mg/500 mg tablet, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimifix M 1 mg/500 mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimifix M 1 mg/500 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glimifix M 1 mg/500 mg Tablets due to potential infant toxicity indicated by available data.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimifix M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. The medication is contraindicated for individuals with severe kidney disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimifix M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients experiencing severe hepatic dysfunction.

What if you forget to take Glimifix M 1 mg/500 mg Tablet :

Should you forget a Glimifix M 1 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimifix M 1 mg/500 mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Glimifix M 1 mg/500 mg Tablet

Store the medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Glimifix M 1 mg/500 mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Glimifix M 1 mg/500 mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimifix M 1 mg/500 mg Tablet, manage type 2 diabetes mellitus (DM) in adults. This dual medication improves blood sugar control when used with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin effectiveness. This formulation is unsuitable for type 1 DM.
Glimifix M 1 mg/500 mg tablets may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Indeed, prolonged Glimifix M 1 mg/500 mg Tablet use can lead to Vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as tingling and numbness in extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Indeed, Glimifix M 1 mg/500 mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Combining Glimifix M 1 mg/500 mg tablets and alcohol is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimifix M 1 mg/500 mg Ta...
44
MRP 53
16% off